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Background: Macroautophagy is a catabolic process that can mediate cell death or survival. Apo2 ligand (Apo2L)/
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) treatment (TR) is known to induce autophagy. Here we
investigated whether SQSTM1/p62 (p62) overexpression, as a marker of autophagic flux, was related to aggressiveness
of human prostate cancer (PCa) and whether autophagy regulated the treatment response in sensitive but not resistant
PCa cell lines.
Methods: Immunostaining and immunoblotting analyses of the autophagic markers p62 [in PCa tissue microarrays
(TMAs) and PCa cell lines] and LC3 (in PCa cell lines), transmission electron microscopy, and GFP-mCherry-LC3 were
used to study autophagy induction and flux. The effect of autophagy inhibition using pharmacologic (3-methyladenine
and chloroquine) and genetic [(short hairpin (sh)-mediated knock-down of ATG7 and LAMP2) and small interfering (si)
RNA-mediated BECN1 knock-down] approaches on TR-induced cell death was assessed by clonogenic survival, sub-G1
DNA content, and annexinV/PI staining by flow cytometry. Caspase-8 activation was determined by immunoblotting.
Results: We found that increased cytoplasmic expression of p62 was associated with high-grade PCa, indicating that
autophagy signaling might be important for survival in high-grade tumors. TR-resistant cells exhibited high autophagic
flux, with more efficient clearance of p62-aggregates in four TR-resistant PCa cell lines: C4-2, LNCaP, DU145, and
CWRv22.1. In contrast, autophagic flux was low in TR-sensitive PC3 cells, leading to accumulation of p62-aggregates.
Pharmacologic (chloroquine or 3-methyladenine) and genetic (shATG7 or shLAMP2) inhibition of autophagy led to cell
death in TR-resistant C4-2 cells. shATG7-expressing PC3 cells, were less sensitive to TR-induced cell death whereas those
shLAMP2-expressing were as sensitive as shControl-expressing PC3 cells. Inhibition of autophagic flux using chloroquine
prevented clearance of p62 aggregates, leading to caspase-8 activation and cell death in C4-2 cells. In PC3 cells,
inhibition of autophagy induction prevented p62 accumulation and hence caspase-8 activation.
Conclusions: We show that p62 overexpression correlates with advanced stage human PCa. Pharmacologic and
genetic inhibition of autophagy in PCa cell lines indicate that autophagic flux can determine the cellular response to TR
by regulating caspase-8 activation. Thus, combining various autophagic inhibitors may have a differential impact on
TR-induced cell death.
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Autophagy is a self degradation process that can medi-
ate cell death as well as survival [1]. Autophagy induced
during starvation, growth factor deprivation, hypoxia,
endoplasmic reticulum (ER) stress, and microbial infec-
tion can prevent cell death [2]. However, it can be also
associated with cell death due to excessive mitophagy,
leading to loss of mitochondrial membrane potential
(Δψm), caspase activation, and lysosomal membrane
permeabilization [3]. Microtubule-associated protein 1
light chain 3 beta (LC3B; also called ATG8) is used as a
marker of autophagy; it is lipidated upon autophagy in-
duction and it is required for autophagosome formation
[4,5]. p62/SQSTM1 (p62) facilitates the degradation of
polyubiquitinated substrates by autophagy, causing its
own degradation; thus it is used as an indicator of au-
tophagic degradation [6].
Apo2L/TRAIL (TNFSF10; clinical name, dulanermin) be-
longs to a small subset of pro-apoptotic protein ligands in
the tumor necrosis factor (TNF) superfamily. As a soluble,
zinc-coordinated homotrimeric protein, it has emerged as a
promising candidate for cancer therapy through its cap-
acity to trigger apoptosis in many types of cancers without
causing significant toxicity to normal cells [7,8]. Apo2L/
TRAIL has also been shown to induce autophagy-
mediated cell death in glioma cells [9,10]. Induction of
autophagy in PCa cells has been shown to mediate cell
survival, and therefore, inhibiting autophagy enhances
drug-induced cell death [11,12].
Recently, p62 has been implicated in activation of
caspase-8 through Apo2L/TRAIL-mediated polyubiqui-
tination of caspase-8 and its association with the death-
inducing signaling complex [13-15]. Consistent with this
notion, a study examining apoptosis in individual cells
has demonstrated that differences in the extent of
caspase-8 activation may be responsible for the cell-to-
cell variation in Apo2L/TRAIL responsiveness [16].
In this study, we investigated the association between
autophagic flux and PCa aggressiveness by immunohisto-
chemical staining for the autophagic marker, p62, in hu-
man prostate tissue microarrays (TMA) consisting of low
to high Gleason scores. In addition, we examined the ef-
fect of autophagy on cell death following Apo2L/TRAIL
treatment (TR) in PCa cell lines. Our data suggest differ-
ential expression of p62 as disease progresses and that au-
tophagic flux can determine the cellular response to TR
by regulating caspase-8 activation.
Results
p62 is over-expressed in the cytoplasm of advanced
human prostate cancer cells
To understand the role of autophagy in human PCa pro-
gression, we examined the expression of SQSTM1/p62
(p62), a marker of autophagic flux in a TMA of humanprostate tissue. The TMA consisted of 51 PCa cases with
Gleason Scores (GS) ranging from 6 (3 + 3) to 8 (4 + 4). Be-
nign prostate tissue adjacent to tumor tissue was present in
TMA cores from 40 of the 51 PCa cases. Using immuno-
histochemical staining, we determined the presence or ab-
sence of autophagy signaling by observing p62 protein
localization, which, when involved in autophagic degrad-
ation, resides in the cytoplasm. In contrast, nuclear p62
participates in directing nuclear polyubiquitinated proteins
to promyelocytic leukemia bodies [17], with no defined role
in autophagy.
Benign prostate tissue showed focal nuclear staining in
14 (35%) cases, with no evidence of cytoplasmic staining
(Figure 1A and C). Remarkably, no cytoplasmic or nuclear
staining for p62 was observed in any GS (3 + 3) 6 PCa
cases (n = 7). Five (19.2%) of GS (3 + 4) 7 PCa cases
showed nuclear staining and 1 (3.8%) showed cytoplasmic
staining for p62. Interestingly, 2 (18.1%) of the GS (4 + 3)
7 PCa cases showed nuclear staining and 4 (36%) dis-
played cytoplasmic p62 expression (Figure 1B and C). Al-
though there was no difference in nuclear staining
between GS (3 + 4) and GS (4 + 3) (19.2% vs.18.1%), the
percentage of cases with cytoplasmic p62 expression in-
creased from 3.8% to 36% (Figure 1B and C). Cytoplasmic
staining for p62 was detected in 5 (71.4%) of GS (4 + 4) 8
PCa cases, one of which showed also focal nuclear stain-
ing. These data indicate that p62 is expressed in the cell
nuclei in benign prostate tissue. In contrast, cytoplasmic
p62 expression increases significantly with increasing GS
(p < 0.05).
Next, p62 mRNA expression was examined in two inde-
pendent PCa microarray data sets available in the Onco-
mine database; p62 mRNA levels were increased in PCa
with high GS compared to adjacent normal prostate tissue
(Figure 1D). As p62 was shown to be involved in the deg-
radation of proteins and cellular organelles by autophagy
in the cytosol [18], the increase in mRNA as well as cyto-
plasmic localization suggested that autophagy might be a
relevant process in high-grade PCa. Therefore, we further
extended this study to determine how autophagy signaling
in PCa affects the response to chemotherapy by investigat-
ing the effect of autophagy signaling in our TR-sensitive
versus TR–resistant PCa cell lines [19].
Apo2L/TRAIL treatment (TR) induces autophagy
LNCaP-derived C4-2 human PCa cells are resistant to TR
[19,20]. Following TR, clonogenic survival declined by up
to 10-fold in PC3, but not in C4-2 cells (Figure 2A). To
study the role of autophagy in regulating cell survival, we
examined the induction of autophagy in these cell lines.
Detecting the presence of autophagic vesicles by using
transmission electron microscopy (TEM) is one of the
most widely used and sensitive techniques to monitor au-
tophagy [21]. Autophagosomes are typically identified as
Figure 1 p62 expression in human prostate cancer (PCa) samples. (A and B) immuno-histochemical staining for p62 in PCa tissue microarrays.
Black arrow: nuclear p62; red arrow: cytoplasmic; blue arrow: no staining (a1), benign prostate tissue with nuclear p62 staining; (a2), benign prostate
tissue with nuclear p62 staining (a3), benign prostate tissue displaying nuclear p62 staining and PCa with cytoplasmic staining; (b1), PCa Gleason score
(GS 4 + 3) 7 with both nuclear (black arrow) and cytoplasmic (red arrow) staining; (b2), PCa Gleason score (4 + 4) 8 with cytoplasmic staining (red
arrow). (C) Nuclear (N) and cytoplasmic (C) p62 expression in benign and various GS (D) mRNA expression analysis in benign prostate tissue (benign
prostate hyperplesia) and various GS human PCa samples from the Oncomine database (p < 0.001).
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tering cellular contents. The immature vesicles have an
electron density lower than or equivalent to the cytoplasm
whereas the mature or late-stage vesicles are characterized
by higher density. We show such representative structures
in Figure 2B. For quantification in Figure 2C, the area cov-
ered by these structures was measured and normalized to
the total cytoplasmic area analyzed. TEM data suggested
that more autophagosomes were present constitutively in
PC3 compared to C4-2 cells (Figure 2B and C). In C4-2
cells there was an early but transient increase in the num-
ber of autophagosomes at 6 h following TR, which de-
clined by 24 h (Figure 2B, bottom and C, right). In PC3,
however, autophagosome formation significantly increased
only after 24 h TR (Figure 2B, bottom and C, left). Also,
TR plus chloroquine (CQ), which inhibits autophagic deg-
radation, compared to CQ alone, resulted in a greater ac-
cumulation of autophagosomes in C4-2 compared to PC3
cells, suggesting that autophagic flux was higher in C4-2
cells (Figure 2B and C). These results demonstrate that
C4-2, but not PC3 cells, exhibit a rapid induction and ef-
fective completion of autophagy in response to TR.
Next, we confirmed autophagic flux by determining
LC3B localization using GFP-mCherry-LC3, which allowsdistinction between autophagosomal and autolysosomal
LC3B as yellow (indicating co-localization of GFP and
mCherry) and red signals, respectively. By time-lapse con-
focal imaging, PC3 cells showed no change in green and
red fluorescence for LC3B until 42 min, suggesting that
autophagosomes remained intact following TR (Figure 3A
and B; Additional file 1: Movie S1 and Additional file 2:
Movie S2). In contrast, C4-2 cells showed decreased green
fluorescence intensity for LC3B at 21 min, with a small de-
crease, if any, in red fluorescence, indicating that autopha-
gosomes were converting into autolysosomes (Figure 3A
and C).
Next, confocal imaging was performed to determine the
total number of autophagosomes and autolysosomes, by
scoring LC3B puncta following TR ± CQ. PC3 cells dis-
played only autophagosomal LC3B-II (yellow puncta on co-
localization), whereas C4-2 showed more autolysosomal
LC3B-II (red) within 2 h of TR (Figure 3D). Co-treatment
with CQ led to accumulation of TR-induced autophagoso-
mal LC3B-II to a larger extent in C4-2 compared to PC3
cells (Figure 3D). Quantitation of autophagosomal and
autolysosomal LC3B puncta also revealed much higher au-
tophagic flux in response to TR in C4-2 compared to PC3
cells (Figure 3E and F). Thus, autophagic flux observed in
Figure 2 Apo2L/TRAIL treatment (TR) induces autophagy. (A) Clonogenic survival assay following TR at the indicated doses (*p < 0.001). (B) Electron
microscopic analyses of autophagic structures at the indicated time following TR ± CQ. Scale bar, 500 nm (C) Quantitative analysis of the autophagic area
normalized to the cytoplasmic area following TR ± CQ (*p < 0.001, **p < 0.05). Data represent means ± SEM (>3 different fields per sample).
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flux in PC3 cells was associated with TR-induced cell death.
Immunofluorescence staining for endogenous LC3B
showed an increase in the number of LC3B puncta in C4-
2 but not PC3 cells following 8 h TR (Additional file 3:
Figure S1A). PC3 cells had, however, more LC3B puncta
constitutively compared to C4-2 cells, indicating a greater
autophagosomal content at baseline, but with no further
induction of autophagy following TR. Addition of CQ
led to accumulation of LC3B puncta in both PC3 and
C4-2 (Additional file 3: Figure S1A). In PC3 cells the
number of LC3 puncta did not significantly increase fol-
lowing TR plus CQ compared to CQ alone. However, in
C4-2 cells the number significantly increased following TR
and was even higher upon addition of CQ (Additional file
3: Figure S1A).
Similar results were obtained with analysis of p62
levels. An autophagy-specific substrate that acts as a
scaffold protein and forms protein aggregates, p62 is di-
rected with its targets to autophagic degradation [22,23].As shown by confocal immunostaining (Figure 3G) and
western blotting (Additional file 3: Figure S1B), after TR
expression of cytoplasmic p62 aggregates are increased
in PC3, whereas p62 expression decreased in C4-2 cells.
Pretreatment with CQ, however, prevented TR-induced
degradation of p62 in C4-2 cells (Additional file 3: Figure
S1B). These findings were extended to all additional PCa
cell lines examined. Similar to C4-2, LNCaP, DU145, and
CWRv22.1 cells exhibited minimal cell death (< 10%) as
opposed to ~ 50% cell death in PC3 cells following TR
(Additional file 3: Figure S1C). Similar to C4-2 cells,
p62 levels as analyzed by western blotting and immuno-
staining, were decreased in the other TR-resistant cell
lines following TR treatment (Additional file 3: Figure S1D
and S1E). Nevertheless, CQ treatment inhibited TR–in-
duced degradation of p62 (Additional file 3: Figure S1D
and S1E). These results suggest that in response to TR, au-
tophagy is induced and high autophagic flux is associated
with cell survival whereas low flux is associated with cell
death.
Figure 3 The autophagic flux is higher in C4-2 compared to PC3 cells. (A-C) Representative confocal time lapse images every 7 min and
quantitation of green and red fluorescence for LC3B expression using GFP-mCherry-LC3 fusion protein stably expressed in PC3 and C4-2 cells
following TR. (D-F) representative confocal images of fixed cells stably expressing GFP-mCherry-LC3 and quantitation of autophagosomal/autolysosomal
LC3B-II puncta in PC3 and C4-2 cells following TR ± CQ. Yellow shows co-localization of GFP and mCherry, indicating completed autophagosomes
(*p < 0.001). Data represent means ± SEM. (G) Representative confocal images of fixed cells for p62 (green) immunostaining following 8 h TR in PC3 and
C4-2 cells. Nuclei were stained with DAPI.
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in C4-2, but not PC3 cells
Next, pharmacological and genetic approaches were used
to study the effect of autophagy induction and completion
on TR-induced cell death in PCa cell lines. Pharmaco-
logical inhibition of autophagy by 3-MA or CQ sensitized
C4-2 cells to TR-induced cell death, with no significant ef-
fect on PC3 cells (Figure 4A and B). For genetic inhibition
of autophagy, lentiviral-mediated shRNA-expressing stable
clones of ATG7 and LAMP2 were generated in PC3 and
C4-2 cells. LC3B-II levels were reduced in shATG7, while
they increased in shLAMP2-expressing cells (Additional
file 4: Figure S2A and S2B). p62 levels were increased in
both shATG7- and shLAMP2-expressing C4-2 and PC3
cells, suggesting that autophagy inhibition resulted in ac-
cumulation of p62 (Additional file 4: Figure S2A and S2B).
The extent of knockdown was > 50% for both ATG7 and
LAMP2 in PC3 and C4-2 cells (Additional file 4: Figure
S2A and S2B). As with 3-MA and CQ, ATG7 and LAMP2-
depleted C4-2 cells formed fewer colonies (Figure 4C) and
underwent cell death (Additional file 5: Figure S3A) in re-
sponse to TR, indicating that they were more sensitive to
TR when autophagy was inhibited. Interestingly, ATG7 de-
pletion in PC3 cells inhibited TR-induced cell death signifi-
cantly (Figure 4D and Additional file 5: Figure S3A). Thus
in TR-sensitive cells, with an intrinsic defect in TR-induced
autophagic flux, inhibition of autophagosome formation at
an early step was protective.Figure 4 Autophagy inhibition prevents cell death in PC3 but enhances
cells following TR (40 ng/ml) ± 3-methyladenine (3-MA) (*p < 0.001). (B) Clono
in (C) C4-2 and (D) PC3 cells stably expressing non-target shRNA, shATG7, orOverall, our data suggest that autophagic clearance
of toxic cellular components is essential for the PCa
cells to survive TR-induced cell death that is associated
with autophagy induction. In TR-sensitive cells TR in-
duces autophagosome-formation; however, due to im-
paired autophagic flux, autophagosome-associated toxic
cellular aggregates are formed, and this results in cell
death. Therefore, inhibiting autophagy induction could
antagonize its effect. In TR-resistant cells that are profi-
cient in autophagic flux, TR-induced accumulation of cel-
lular aggregates is prevented and the cells survive. Thus,
inhibition of the autophagic pathway in TR-resistant cells
leads to accumulation of protein aggregates and sensitizes
these cells to TR. Thus, TR-induced autophagy causes cell
death in TR-sensitive cells, whereas it has a prosurvival
role in TR-resistant cells due to differential autophagic
flux.
Caspase-8 can be proteolytically cleaved to a p18-kD
fragment through its association with p62 aggregates,
leading to its complete activation and ensuing apoptosis
[13]. Since differential autophagic flux in PCa cells deter-
mined cell death in response to TR, we investigated
whether the impaired or inhibited autophagic flux led to
cell death in response to TR by accumulation of p62 and
subsequent activation of caspase-8. Our data suggest that,
indeed, PC3 cells with impaired flux showed the pro- and
cleaved (p43/p41)-forms of caspase-8 and its fully acti-
vated p18-kD form following TR (Figure 5A). In contrast,cell death in C4-2 cells. (A) Clonogenic survival assay in PC3 and C4-2
genic survival assay following TR ± CQ (*P < 0.001). Clonogenic survival
shLAMP2, with the indicated doses of TR (*p < 0.001).
Figure 5 Impaired autophagic flux causes apoptosis in PCa cells by caspase-8 activation. (A) Western blot analysis for caspase-8 activation
following TR. β-actin served as loading control. (B) Clonogenic survival in PC3 cells stably expressing non-target shRNA, shATG7, or shLAMP2, after
TR (40 ng/ml) ± caspase-8 inhibitor z-IETD-fmk (10 μM) for 24 h (*p < 0.001). Western blot analysis of the indicated proteins in (C) C4-2 cells
following TR ± CQ, and (D) PC3 cells following TR ± 3-MA or (E) PC3 cells expressing non-target siRNA or siBECN1 following TR.
Singh et al. Molecular Cancer 2014, 13:70 Page 7 of 11
http://www.molecular-cancer.com/content/13/1/70C4-2 cells showed only the p43/p41 forms of caspase-8, in-
dicating that the full activation of caspase-8 necessary for
apoptosis was absent (Figure 5A). TR-induced cell death
was significantly impaired in PC3, with minimal effect on
C4-2 cells following inhibition of caspase activation by the
pan-caspase inhibitor z-VAD-fmk or the caspase-8 specific
inhibitor z-IETD-fmk, as determined by annexinV/PI stain-
ing (Additional file 5: Figure S3B). z-IETD-fmk inhibition
of caspase-8 also prevented cell death in PC3 cells express-
ing shATG7 and shLAMP2 (Figure 5B). Consistently, in
C4-2 cells inhibition of autophagic flux using CQ pre-
treatment, as measured by inhibition of p62 degradation
following TR treatment (Figure 5C), led to TR-induced
accumulation of the fully activated p18-kD form of
caspase-8 (Figure 5C). Similarly, in PC3 cells both 3-
MA pretreatment and siBECN1-expression led to a de-
crease in TR-induced cleaved caspase-8 levels (Figure 5D
and E, respectively). These results confirmed that autoph-
agy induction was required for TR-induced apoptosis in
PC3 cells, which depended on caspase-8 activation.
Thus, a constitutive defect in autophagic flux in re-
sponse to TR causes inhibition of autophagic clearanceof p62 aggregates that, in turn, results in caspase-8 acti-
vation, leading to cell death in PC3 cells. However, in
TR-resistant C4-2 cells, complete autophagy signaling
leads to clearance of p62 aggregates, and hence activa-
tion of caspase-8 is prevented, thereby facilitating cell
survival.
Discussion
In this study we show that autophagy is critical for PCa
pathogenesis, as p62 is overexpressed in the cytoplasm of
high grade PCa. In contrast, in benign tissue it is only
expressed in the cell nuclei, suggesting that p62 has a more
basic function apart from autophagy [17]. Interestingly,
cytoplasmic p62 expression is positively associated with the
aggressiveness of the disease. These findings suggest that
p62 could be a potential molecular biomarker for PCa pro-
gression and that elevated autophagy might be an import-
ant factor for disease progression, maintenance of tumor
homeostasis in higher grade PCa, or both. In addition to its
principal role of maintaining cellular homeostasis in health
and disease, during chemotherapy, autophagy counterbal-
ances the cellular stress generated by chemotherapeutic
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homeostasis [24,25]. Therefore, autophagy inhibition has
recently emerged as a potential therapeutic approach to in-
duce cell death in cancer cells. The dependence of PCa on
this pathway is, therefore, exploitable for therapeutic
benefit.
We have previously shown that the combination of
CPT-11 with TR increases apoptosis in C4-2 PCa cells,
which are otherwise resistant to TR [19,20]. Autophagy
mediates cell survival in tumor cells and serves as a mech-
anism of resistance against many chemotherapeutics, in-
cluding TR [26]. Here, we have identified autophagy as a
mediator of cell survival in four TR-resistant PCa cell
lines. These TR-resistant PCa cells exhibited high autoph-
agic flux, in contrast to TR-sensitive PC3 cells, in which
autophagic flux was low, preventing completion of au-
tophagy and leading to autophagosome accumulation.
TR led to degradation of p62 and prevented caspase-8
activation in TR-resistant cells. However, in TR-sensitive
cells, accumulation of autophagosomes and p62 protein
aggregates, which were associated with impaired autopha-
gic degradation, led to caspase-8 activation and apoptosis.
Consistently, inhibition of autophagy pharmacologically or
genetically by shRNA-mediated knockdown of ATG7 and
LAMP2 sensitized C4-2 cells to TR. Importantly, inhib-
ition of autophagy at the different steps in the autophagy
pathway led to different outcomes for TR-induced cell
death in PC3 cells. Thus, when autophagy was inhibited
by 3-MA, siBECN1, or shATG7 before the association of
LC3 with the autophagosomal membranes, p62 aggregate
formation and subsequent caspase-8 activation was pre-
vented, and cell death was inhibited. In contrast, inhibiting
autophagic degradation using CQ or shLAMP2 had no ef-
fect on TR-induced cell death in PC3 cells. These findings
suggest that accumulation of autophagosomes and p62
protein aggregates in the absence of autophagic degrad-
ation is sufficient for TR-induced cell death. Levels of
LAMP2 were decreased in TR-sensitive compared to TR-
resistant cells (data not shown), supporting the notion that
autophagic degradation was inhibited in TR-sensitive cells.
This was also true in a small-lung carcinoma model,
where LAMP2 was down-regulated in TR-sensitive as
compared to TR-resistant groups [14]. These findings fur-
ther support our conclusion that autophagic degradation
is impaired in TR-sensitive tumor cell lines.
Conclusions
In summary, we define how the extent and nature of au-
tophagic signaling can determine the response to TR
that may be exploited for further clinical development of
dulanermin or agonistic antibodies against the Apo2L/
TRAIL receptors. Establishing the extent of autophagy
in different grades of PCa will be useful for designing
better therapeutic modalities by combining autophagyinhibitors currently in clinical trials [27]. It has been re-
cently suggested that of the NIH-funded PCa clinical tri-
als currently recruiting, 60% are testing interventions
known to exert at least a moderate effect on autophagy
[28]. These include autophagy inhibitors (e.g. hydroxy-
chloroquine) and therapeutics that impact autophagy, ei-
ther directly, such as mTOR inhibitors (e.g. everolimus),
or indirectly, such as inhibitors of PI3K and AKT. More-
over, in patients with caloric or metabolic deregulation
(such as those who are obese) autophagy may have a
greater impact, as might agents that modulate it and,
therefore, based on our findings, such patients could be
stratified for individualized treatments.
Methods
Reagents and plasmids
Recombinant Apo2L/TRAIL (dulanermin) was a gener-
ous gift from Genentech. The following reagents were
purchased: chloroquine (CQ), 3-methyladenine (3-MA),
acridine orange, and propidium iodide (Sigma-Aldrich).
The GFP-mCherry-LC3B and pCL10 plasmids were a kind
gift from Dr. Jayanta Debnath (University of California
San Francisco). The lentiviral packaging plasmids pVSVG
and dr 8.7 were from Invitrogen. pLKO.1–puro control
vector, shATG7, and shLAMP2 (SHCLNG-NM_006395,
SHCLNG-NM_002294) Mission shRNAs were from
Sigma-Aldrich. siBECN1 (sc-29797) and control siRNA
(Fluorescein Conjugate)-A (sc-36869) were from Santa
Cruz Biotechnology. Fugene was from Roche Applied Sci-
ence. The following antibodies were used; p62 (Fitzgerald
Industries International); LAMP2, p62, BECN1 (Santa Cruz
Biotechnologies); ATG7 (Cell Signaling Technologies), β-
actin (Sigma Aldrich); Caspase-8 (C-15; Alexis); secondary
anti-mouse HRP (Millipore); and secondary anti-rabbit
HRP (Fisher Scientific).
Cell culture and treatments
PCa cell lines PC3, LNCaP, DU145, CWRv22.1, and
LNCaP-derived C4-2 were maintained in RPMI 1640
media. All media were supplemented with 10% fetal bo-
vine serum (FBS, Atlanta Biologicals), L-glutamine, and
100 unit/ml penicillin-streptomycin (Invitrogen). Cells
were grown in a humidified incubator at 37°C and 5%
CO2. Cells were treated with 100 ng/ml Apo2L/TRAIL
(dulanermin) or CQ and 10 mM of 3-MA, unless speci-
fied otherwise.
Tissue specimens
Human prostate tissue was from 51 radical prostatectomy
specimens from patients with PCa with different Gleason
score (GS) including GS (3 + 3) 6 (n = 7), GS (3 + 4) 7 (n =
26), GS (4 + 3) 7 (n = 11), GS (4 + 4) 8 (n = 7) on TMA
slides containing 2 to 3 cores per sample. Benign adjacent
prostate tissue was present in 40 of the 51 cases. Tissue
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Cleveland Clinic as part of an IRB-approved protocol.
Immunohistochemical staining for p62 in human prostate
cancer samples
Immunohistochemistry with a monoclonal p62 antibody
was performed on formalin-fixed paraffin-embedded TMA
sections mounted on poly L-lysine-coated slides. The sec-
tions were deparaffinized in xylene and rehydrated through
graded alcohols into distilled water. Antigen retrieval was
in 0.1 M citrate buffer using a pressure cooker at 95°C for
15 min. Immunostaining was performed by using an im-
munohistochemistry kit according to the manufacturer’s
instructions (Invitrogen) after incubation with primary
antibody to p62 (Santa Cruz Biotechnologies) for 1 h.
Non-immune pooled mouse immunoglobulin was used as
a negative control. Sections were incubated in secondary
antibody for 1 h followed by colorimetric detection using
chromogen in accordance with the manufacturers’ proto-
cols (Dako). Slides were then counterstained with haema-
toxylin, rinsed, and dehydrated through graded alcohols
into non-aqueous solution and cover-slipped with mount-
ing media.
Analysis of GFP-mCherry-LC3 puncta
During autophagy, LC3B-II is recruited to the autophago-
somal membranes and continues to be present on the
membranes of completed autophagosomes, which can be
visualized as a yellow signal because GFP and mCherry
co-localize. In autolysosomes, because of the acidic pH,
the GFP fluorescence is diminished while mCherry still re-
mains stable. Thus, the conversion of yellow LC3B-II
puncta to red LC3-II puncta provides a readout for autoph-
agic flux. Cells with stable expression of GFP-mCherry-LC3
were grown overnight before treatment and fixed with
2% paraformaldehyde, washed several times with PBS,
mounted using Vectashield, and analyzed using an HCX
Plan Apo 63×/1.4N.A. oil immersion objective lens on a
Leica TCS-SP2 confocal microscope (Leica Microsystems
AG). LC3B puncta were quantified using the Red and
Green Puncta Co-localization Macro with the Image J pro-
gram, as described [29,30].
Confocal immunostaining
Cells were plated at 2 × 105 cells/cm2 on 22 × 22 mm cov-
erslips in 35-mm culture dishes. Immunostaining was per-
formed as previously described [30]. Briefly, following the
respective treatments, cells were fixed with 2.0% parafor-
maldehyde/PBS for 15 min, washed 3× for 10 min each,
permeabilized with 0.1% Triton X-100 in PBS for 5 min
and blocked in 10% FBS in PBS for 1 h. The coverslips
were then immunostained using the antibodies diluted in
blocking buffer, followed by fluorescently-conjugated sec-
ondary antibody. DAPI was added to stain nuclei beforethe penultimate washing. They were then mounted in
Vectashield (Vector Laboratories). Images were collected
using an HCX Plan Apo 63×/1.4N.A. oil immersion object-
ive lens on a Leica TCS-SP2 confocal microscope (Leica
Microsystems AG).
Electron microscopic analyses
Cells were immediately fixed in 2.5% glutaraldehyde/4%
formaldehyde in 0.1 M Cacodylate buffer, pH 7.3, for 24 h,
followed by post-fixation with 1% osmium tetroxide for 1 h.
After en bloc staining and dehydration with ethanol, the
samples were embedded with eponate 12 medium (Ted
Pella Inc, Redding, CA). Thin sections (85 nm) were cut
with a diamond knife, double-stained with uranyl acetate
and lead citrate, and analyzed using a Philips CM12 electron
microscope (FEI Company) operated at 60 kv. Cells with
more than 10 vacuoles were scored as autophagy positive.
The autophagic area was quantified as described previously
[30]. At least 10 cells per sample were used for quantitation.
The size of autophagic structures was represented as relative
area values calculated by selecting specific areas using Image
J. The autophagic area was calculated as the percentage frac-
tion normalized to the total cytoplasmic area.
Lentiviral transduction of shRNA
shRNA target sequences were: ATG7 3′UTR, 5′-CCGG
GCCTGCTGAGGAGCTC TCCATCTCGAGATGGAGA
GCTCCTCAGCAGGCTTTT-3′ and LAMP2 CDS-5′-C
CGGGCC ATCAGAATTCCAT TGAATCTCGAGATTC
AATGGA ATTCTGATGGCTTTTT-3′. 293T cells were
transfected with these shRNAs together with the pVSVG
and dr8.2 plasmids in a 3:1:1 ratio using the Fugene trans-
fection reagent. Media containing viral particles was then
collected 24 h after transfection, passed through a 0.8-mi-
cron filter, and added to PC3 and C4-2 cells along with
polybrene (10 μg/ml). After overnight incubation at 37°C,
the medium was replenished, and cells were selected for
puromycin resistance (2 μg/ml) for 3 days, after which
knockdown was further validated. For control pLKO.1
vector and non-target shRNA-expressing stable cell lines
were generated as described [30].Cell death and survival analyses
Cell viability was determined by staining with annexinV-
FITC and propidium iodide (PI) followed by flow cyto-
metric analysis on a FACScan with a 488 nm argon laser
(BD Biosciences). Analyses were performed with the Cell
Quest program. For clonogenic survival, cells were
plated in 6-well plates in triplicate. Following drug treat-
ments, cells were allowed to grow for 14 days, fixed, and
stained in methanol:acetic acid (75:25, v/v) containing
0.5% crystal violet (w/v) to visualize colonies of at least
50 cells. The absolute number of colonies was plotted.
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Cells were grown in 35-mm glass bottom dishes (MatTek)
and imaged using an UltraVIEW VoX spinning disc
confocal microscope (Perkin Elmer) equipped with a
high-sensitivity cooled 14-bit EMCCD C9100-13 cam-
era (Hamamatsu). During imaging, cells were kept in a
heated incubation chamber at 37°C with CO2 (LiveCell,
Pathology Devices, Inc.). Volocity image acquisition
software was used to capture the images (Perkin Elmer).
The track analysis and intensity measurements were
done with Image Pro 7.0 (Media Cybernetics).
Statistical analyses
We analyzed the correlation between cytoplasmic expres-
sion of p62 and Gleason score by Pearson’s correlation
analysis (Prism v.5, GraphPad Software, Inc.). All the
remaining data were obtained from at least three inde-
pendent experiments carried out in triplicate with the
error bars denoting SEM. P values were determined by
Student’s t-test (Microsoft Excel).
Additional files
Additional file 1: Movie S1. GFP-mCherry-LC3 puncta formation in PC3
cells. Confocal time-lapse video of PC3 cells stably expressing GFP-
mCherry-LC3 following TR. The arrow represents one of the highlighted
autophagosomes shown in Figure 3A.
Additional file 2: Movie S2. GFP-mCherry-LC3 puncta formation in
C4-2 cells. Confocal time-lapse video of C4-2 cells stably expressing
GFP-mCherry-LC3 following TR. The arrow represents one of the
highlighted autophagosomes shown in Figure 3A.
Additional file 3: Figure S1. Autophagic flux is higher in TR-resistant
cells. PC3 and C4-2 cells were treated with Apo2L/TRAIL (TR) ± chloroquine
(CQ). (A) Representative confocal immunostaining of endogenous LC3
puncta-positive cells. (blue= DAPI, red=LC3). (B) Western blotting analysis of
p62 and β-actin was used as loading control. (C) Cell death is shown as
percentage of cells with sub-G1 DNA content at the indicated time follow-
ing TR (*p<0.001). ). Indicated cell lines were treated with TR ± CQ and p62
levels were analyzed by (D) Western blotting and β-actin was used as a
loading control. (E) confocal immunostaining of endogenous p62.
Additional file 4: Figure S2. Inhibition of autophagy in PC3 and C4-2
cells by shRNA-mediated stable knockdown of ATG7 and LAMP2. (A and
B) Cells were treated with HBSS in order to determine starvation-induced
autuohagy. Western blot analysis showing levels of LC3, p62, ATG7 and
LAMP2 in PC3 and C4-2 cells stably expressing shATG7 or shLAMP2 (+),
respectively, compared to non-target shRNA controls (NT) (-). β-actin
served as a loading control.
Additional file 5: Figure S3. Impaired autophagic degradation, led to
caspase-8 activation and apoptosis in TR-sensitive cells. (A) Annexin V-FITC/PI
staining to determine % cell death in PC3 and C4-2 cells stably- expressing
non-target shRNA, shATG7, or shLAMP2, at 24 h following TR (*P<0.001). (B)
Annexin V-FITC/PI staining to determine % cell death in PC3 and C4-2 cells
at 24 h following TR ± z-VAD or z-IETD-fmk (caspase 8 inhibitor) (*P<0.001).
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